Subsequently, HCC samples were divided into AP4M1-high and AP4M1-low expression groups, and we sought to determine whether various expression groups of AP4M1 differ in the HCC tumor immune microenvironment. Here, AP4M1 is linked to hepatocellular carcinoma.